Dr Kenneth Watterson

  • Lecturer (Life Sciences General Teaching)

telephone: 1900
email: Kenneth.Watterson@glasgow.ac.uk

Publications

List by: Type | Date

Jump to: 2017 | 2016 | 2015 | 2014
Number of items: 6.

2017

Shaw, A., Jeromson, S., Watterson, K. R., Pediani, J. D. , Gallagher, I., Whalley, T., Dreczkowski, G., Brooks, N., Galloway, S. and Hamilton, D. L. (2017) Multiple AMPK activators inhibit L-Carnitine uptake in C2C12 skeletal muscle myotubes. American Journal of Physiology: Cell Physiology, 312(6), C689-C696. (doi:10.1152/ajpcell.00026.2016) (PMID:28298333)

Watterson, K. R. et al. (2017) Probe-dependent negative allosteric modulators of the long-chain free fatty acid receptor FFA4. Molecular Pharmacology, 91(6), pp. 630-641. (doi:10.1124/mol.116.107821) (PMID:28385906) (PMCID:PMC5438128)

2016

Azevedo, C. M. G. et al. (2016) Non-acidic free fatty acid receptor 4 agonists with antidiabetic activity. Journal of Medicinal Chemistry, 59(19), pp. 8868-8878. (doi:10.1021/acs.jmedchem.6b00685)

2015

Milligan, G. , Alvarez-Curto, E. , Watterson, K.R., Ulven, T. and Hudson, B.D. (2015) Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4. British Journal of Pharmacology, 172(13), pp. 3254-3265. (doi:10.1111/bph.12879) (PMID:25131623)

Christiansen, E. et al. (2015) Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases. British Journal of Nutrition, 113(11), pp. 1677-1688. (doi:10.1017/S000711451500118X) (PMID:25916176)

2014

Watterson, K. R., Hudson, B. D. , Ulven, T. and Milligan, G. (2014) Treatment of type 2 diabetes by free fatty acid receptor agonists. Frontiers in Endocrinology, 5, 137. (doi:10.3389/fendo.2014.00137) (PMID:25221541) (PMCID:PMC4147718)

This list was generated on Wed Nov 13 22:36:15 2019 GMT.
Jump to: Articles
Number of items: 6.

Articles

Shaw, A., Jeromson, S., Watterson, K. R., Pediani, J. D. , Gallagher, I., Whalley, T., Dreczkowski, G., Brooks, N., Galloway, S. and Hamilton, D. L. (2017) Multiple AMPK activators inhibit L-Carnitine uptake in C2C12 skeletal muscle myotubes. American Journal of Physiology: Cell Physiology, 312(6), C689-C696. (doi:10.1152/ajpcell.00026.2016) (PMID:28298333)

Watterson, K. R. et al. (2017) Probe-dependent negative allosteric modulators of the long-chain free fatty acid receptor FFA4. Molecular Pharmacology, 91(6), pp. 630-641. (doi:10.1124/mol.116.107821) (PMID:28385906) (PMCID:PMC5438128)

Azevedo, C. M. G. et al. (2016) Non-acidic free fatty acid receptor 4 agonists with antidiabetic activity. Journal of Medicinal Chemistry, 59(19), pp. 8868-8878. (doi:10.1021/acs.jmedchem.6b00685)

Milligan, G. , Alvarez-Curto, E. , Watterson, K.R., Ulven, T. and Hudson, B.D. (2015) Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4. British Journal of Pharmacology, 172(13), pp. 3254-3265. (doi:10.1111/bph.12879) (PMID:25131623)

Christiansen, E. et al. (2015) Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases. British Journal of Nutrition, 113(11), pp. 1677-1688. (doi:10.1017/S000711451500118X) (PMID:25916176)

Watterson, K. R., Hudson, B. D. , Ulven, T. and Milligan, G. (2014) Treatment of type 2 diabetes by free fatty acid receptor agonists. Frontiers in Endocrinology, 5, 137. (doi:10.3389/fendo.2014.00137) (PMID:25221541) (PMCID:PMC4147718)

This list was generated on Wed Nov 13 22:36:15 2019 GMT.